Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
NCT05406115
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
AMG 786
OTHER:
Placebo
Sponsor
Amgen